Novolex CEO and leadership

Stanley Bikulege is a Chairman at Novolex and Chief Executive Officer at Novolex.

Adrianne Tipton, PhD is Chief Technology Officer, responsible for driving innovation in new product development, product management and product marketing. With more than 20 years of experience, Tipton provides extensive expertise in a wide variety of areas, including business strategy, marketing, research and new product development. Before joining Novolex, she was Vice President of Business Research for ORC International as well as Vice President of New Product Development and Marketing for Cenveo (formerly National Envelope). Previous to that, Tipton served a variety of critical roles in research and development at Clorox and was Key Account Manager/Senior Process Engineer for Novellus Systems. Tipton holds a Bachelor of Sciences degree in chemistry from Northern Arizona University, a PhD in synthetic bioorganic chemistry from the University of Nevada, Reno and a post-doctoral fellowship from the Center for Metals in Biocatalysis from the University of Minnesota.

Norman leads Novolex's finance organization and is responsible for finance, accounting, treasury, risk management and information technology.

Norman joins Novolex from nThrive, Inc., a healthcare IT and services company, where he contributed to significant transformation at the company including integrating multiple acquisitions. Prior to that, Dennis spent 16 years as an executive leader in charge of strategic planning, finance and corporate development at Polymer Group, Inc./Avintiv, Inc., the last six years as CFO.

Stanley Bikulege is a Chairman at Novolex and Chief Executive Officer at Novolex.